The stock of Avalon GloboCare Corp (ALBT) has gone down by -47.91% for the week, with a -30.12% drop in the past month and a -46.48% drop in the past quarter. The volatility ratio for the week is 16.85%, and the volatility levels for the past 30 days are 19.84% for ALBT. The simple moving average for the past 20 days is -28.62% for ALBT’s stock, with a -56.20% simple moving average for the past 200 days.
Is It Worth Investing in Avalon GloboCare Corp (NASDAQ: ALBT) Right Now?
The stock has a 36-month beta value of 0.29.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ALBT is 0.40M, and at present, short sellers hold a 3.45% of that float. On November 05, 2024, the average trading volume of ALBT was 369.35K shares.
ALBT) stock’s latest price update
The stock price of Avalon GloboCare Corp (NASDAQ: ALBT) has plunged by -23.81 when compared to previous closing price of 2.94, but the company has seen a -47.91% decline in its stock price over the last five trading sessions. globenewswire.com reported 2024-10-25 that FREEHOLD, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and laboratory services, today announced that it entered into a memorandum of understanding (the “MOU”) with Qi Diagnostics Limited (“Qi Diagnostics”), a nanosensor-based diagnostic technologies company, to explore a proposed strategic collaboration to co-develop a VOC (volatile organic compound) nanosensor-based point-of-care cannabis breathalyzer. The MOU provides Avalon with an exclusivity period of 120 days (the “Exclusivity Period”), during which Avalon intends to negotiate with Qi Diagnostics and enter into a definitive agreement regarding the proposed strategic collaboration.
ALBT Trading at -35.38% from the 50-Day Moving Average
After a stumble in the market that brought ALBT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -89.63% of loss for the given period.
Volatility was left at 19.84%, however, over the last 30 days, the volatility rate increased by 16.85%, as shares sank -28.55% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -50.76% lower at present.
During the last 5 trading sessions, ALBT fell by -47.91%, which changed the moving average for the period of 200-days by -64.86% in comparison to the 20-day moving average, which settled at $3.14. In addition, Avalon GloboCare Corp saw -69.08% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ALBT
Current profitability levels for the company are sitting at:
- -3.18 for the present operating margin
- 0.14 for the gross margin
The net margin for Avalon GloboCare Corp stands at -11.23. The total capital return value is set at -0.38. Equity return is now at value -128.85, with -58.06 for asset returns.
Based on Avalon GloboCare Corp (ALBT), the company’s capital structure generated 0.65 points at debt to capital in total, while cash flow to debt ratio is standing at -0.52. The debt to equity ratio resting at 1.87. The interest coverage ratio of the stock is -1.81.
Currently, EBITDA for the company is -6.85 million with net debt to EBITDA at -2.12. When we switch over and look at the enterprise to sales, we see a ratio of 8.08. The receivables turnover for the company is 14.47for trailing twelve months and the total asset turnover is 0.07. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.06.
Conclusion
To sum up, Avalon GloboCare Corp (ALBT) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
